BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 26828271)

  • 1. GSE1 negative regulation by miR-489-5p promotes breast cancer cell proliferation and invasion.
    Chai P; Tian J; Zhao D; Zhang H; Cui J; Ding K; Liu B
    Biochem Biophys Res Commun; 2016 Feb; 471(1):123-8. PubMed ID: 26828271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miR-424-5p regulates cell proliferation, migration and invasion by targeting doublecortin-like kinase 1 in basal-like breast cancer.
    Wang J; Wang S; Zhou J; Qian Q
    Biomed Pharmacother; 2018 Jun; 102():147-152. PubMed ID: 29550638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RNA-sequence-based microRNA expression signature in breast cancer: tumor-suppressive miR-101-5p regulates molecular pathogenesis.
    Toda H; Seki N; Kurozumi S; Shinden Y; Yamada Y; Nohata N; Moriya S; Idichi T; Maemura K; Fujii T; Horiguchi J; Kijima Y; Natsugoe S
    Mol Oncol; 2020 Feb; 14(2):426-446. PubMed ID: 31755218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR 1296-5p Inhibits the Migration and Invasion of Gastric Cancer Cells by Repressing ERBB2 Expression.
    Shan X; Wen W; Zhu D; Yan T; Cheng W; Huang Z; Zhang L; Zhang H; Wang T; Zhu W; Zhu Y; Zhu J
    PLoS One; 2017; 12(1):e0170298. PubMed ID: 28099468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of miR-660-5p expression suppresses tumor development and metastasis in human breast cancer.
    Shen Y; Ye YF; Ruan LW; Bao L; Wu MW; Zhou Y
    Genet Mol Res; 2017 Feb; 16(1):. PubMed ID: 28252173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MiR-361-5p inhibits glycolytic metabolism, proliferation and invasion of breast cancer by targeting FGFR1 and MMP-1.
    Ma F; Zhang L; Ma L; Zhang Y; Zhang J; Guo B
    J Exp Clin Cancer Res; 2017 Nov; 36(1):158. PubMed ID: 29132384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GSE1 predicts poor survival outcome in gastric cancer patients by SLC7A5 enhancement of tumor growth and metastasis.
    Ding K; Tan S; Huang X; Wang X; Li X; Fan R; Zhu Y; Lobie PE; Wang W; Wu Z
    J Biol Chem; 2018 Mar; 293(11):3949-3964. PubMed ID: 29367342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-17-5p promotes human breast cancer cell migration and invasion through suppression of HBP1.
    Li H; Bian C; Liao L; Li J; Zhao RC
    Breast Cancer Res Treat; 2011 Apr; 126(3):565-75. PubMed ID: 20505989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-411-5p inhibits proliferation and metastasis of breast cancer cell via targeting GRB2.
    Zhang Y; Xu G; Liu G; Ye Y; Zhang C; Fan C; Wang H; Cai H; Xiao R; Huang Z; Luo Q
    Biochem Biophys Res Commun; 2016 Aug; 476(4):607-613. PubMed ID: 27264952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sinomenine inhibits breast cancer cell invasion and migration by suppressing NF-κB activation mediated by IL-4/miR-324-5p/CUEDC2 axis.
    Song L; Liu D; Zhao Y; He J; Kang H; Dai Z; Wang X; Zhang S; Zan Y
    Biochem Biophys Res Commun; 2015 Aug; 464(3):705-10. PubMed ID: 26166821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-139-5p inhibits cell proliferation and invasion by targeting insulin-like growth factor 1 receptor in human non-small cell lung cancer.
    Xu W; Hang M; Yuan CY; Wu FL; Chen SB; Xue K
    Int J Clin Exp Pathol; 2015; 8(4):3864-70. PubMed ID: 26097570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MiR-31 inhibits migration and invasion by targeting SATB2 in triple negative breast cancer.
    Luo LJ; Yang F; Ding JJ; Yan DL; Wang DD; Yang SJ; Ding L; Li J; Chen D; Ma R; Wu JZ; Tang JH
    Gene; 2016 Dec; 594(1):47-58. PubMed ID: 27593563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circ_0001982 aggravates breast cancer development through the circ_0001982-miR-144-3p-GSE1 axis.
    Gao F; Han J; Jia L; He J; Wang Y; Chen M
    J Biochem Mol Toxicol; 2024 Jan; 38(1):e23565. PubMed ID: 37867456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-601 is a prognostic marker and suppresses cell growth and invasion by targeting PTP4A1 in breast cancer.
    Hu JY; Yi W; Wei X; Zhang MY; Xu R; Zeng LS; Huang ZJ; Chen JS
    Biomed Pharmacother; 2016 Apr; 79():247-53. PubMed ID: 27044835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-96 promotes tumor proliferation and invasion by targeting RECK in breast cancer.
    Zhang J; Kong X; Li J; Luo Q; Li X; Shen L; Chen L; Fang L
    Oncol Rep; 2014 Mar; 31(3):1357-63. PubMed ID: 24366472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-125b-5p inhibits breast cancer cell proliferation, migration and invasion by targeting KIAA1522.
    Li Y; Wang Y; Fan H; Zhang Z; Li N
    Biochem Biophys Res Commun; 2018 Sep; 504(1):277-282. PubMed ID: 30177391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-296/Scribble axis is deregulated in human breast cancer and miR-296 restoration reduces tumour growth in vivo.
    Savi F; Forno I; Faversani A; Luciani A; Caldiera S; Gatti S; Foa P; Ricca D; Bulfamante G; Vaira V; Bosari S
    Clin Sci (Lond); 2014 Aug; 127(4):233-42. PubMed ID: 24527800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-491-5p functions as a tumor suppressor by targeting JMJD2B in ERα-positive breast cancer.
    Hui Z; Yiling C; Wenting Y; XuQun H; ChuanYi Z; Hui L
    FEBS Lett; 2015 Mar; 589(7):812-21. PubMed ID: 25725194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-127 is downregulated by Tudor-SN protein and contributes to metastasis and proliferation in breast cancer cell line MDA-MB-231.
    Zhao X; Duan Z; Liu X; Wang B; Wang X; He J; Yao Z; Yang J
    Anat Rec (Hoboken); 2013 Dec; 296(12):1842-9. PubMed ID: 24155205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Downregulation of β3 integrin by miR-30a-5p modulates cell adhesion and invasion by interrupting Erk/Ets‑1 network in triple-negative breast cancer.
    Li W; Liu C; Zhao C; Zhai L; Lv S
    Int J Oncol; 2016 Mar; 48(3):1155-64. PubMed ID: 26781040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.